loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 205832 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BOEHRINGER INGELHEIM (2)

filter

01 CAPSULE;ORAL (2)

filter

01 RX (2)

filter

01 OFEV (2)

filter

01 Yes (2)

URL Supplier Web Content
CAPSULE; ORAL
EQ 100MG BASE
2014-10-15
205832
OFEV
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 150MG BASE
2014-10-15
205832
OFEV
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 205832

Looking for FDA Orange Book APPLICATION 205832 2

19

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is NINTEDANIB ESYLATE, with a corresponding application number 205832.

Regulatory Information RX

With a dosage strength EQ 100MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 2014-10-15

18

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is NINTEDANIB ESYLATE, with a corresponding application number 205832.

Regulatory Information RX

With a dosage strength EQ 150MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 2014-10-15

Post Enquiry
POST ENQUIRY